A Study of LXR015-1 in HIV-Infected Patients

A Clinical Trial To Evaluate the Toxicity and Antiviral Effects of a Range of Doses of Ampligen in p24 Antigen Positive HIV-Infected Patients With AIDS or ARC

NCT00000735 ·Status: COMPLETED ·Phase: PHASE1

Vaccine Treatment for HIV-Infection

NCT00108654 ·Status: COMPLETED ·Phase: PHASE1

A Study of Raltegravir in a Diverse Cohort of HIV-Infected Patients (0518-055)

NCT00764946 ·Status: COMPLETED ·Phase: PHASE3

Study of EBT-101 in Aviremic HIV-1 Infected Adults on Stable ART

NCT05144386 ·Status: COMPLETED ·Phase: PHASE1

Safety and Therapeutic Efficacy of the VRC01 Antibody in Patients Who Initiated Antiretroviral Therapy During Early Acute HIV Infection

NCT02664415 ·Status: COMPLETED ·Phase: PHASE2

Safety of Recombinant HIV Vaccines in HIV Infected Young Adults on Stable Therapy

NCT00107549 ·Status: COMPLETED ·Phase: PHASE1

HIV Vaccine Study in HIV Positive Patients

NCT01071031 ·Status: COMPLETED ·Phase: PHASE1

MK6186 in HIV-1 Infected Patients (MK-6186-007 AM2)

NCT01152255 ·Status: TERMINATED ·Phase: PHASE1

Trial of the Safety and Immunogenicity of an Oral, Replicating Ad26 Vectored HIV-1 Vaccine

NCT02366013 ·Status: COMPLETED ·Phase: PHASE1

A Study of 1592U89 in HIV-Infected Adults

NCT00002200 ·Status: COMPLETED ·Phase: NA

Study of HIV-1 Rgp-160 Administered by Mucosal Routes in Healthy Volunteers

NCT00122564 ·Status: TERMINATED ·Phase: PHASE1

Safety and Immune Response to a Prime-Boost Vaccination Schedule in HIV-infected Patients

NCT00270465 ·Status: COMPLETED ·Phase: PHASE1

A Study of the Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRCHIVMAB0115-00-AB (VRC01.23LS), Administered Intravenously or Subcutaneously to Healthy Adults

NCT05627258 ·Status: COMPLETED ·Phase: PHASE1

A Phase I Study of Recombinant CD4(rCD4) in Patients With AIDS and AIDS-Related Complex

NCT00002005 ·Status: COMPLETED ·Phase: NA

Phase I Study to Evaluate the Safety and Immunogenicity of HIV-1 Immunogen in Children With HIV-1 Infection

NCT00001445 ·Status: COMPLETED ·Phase: PHASE1

Safety and Activity of the Oral HIV Entry Inhibitor AMD11070 in HIV Infected Patients

NCT00089466 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety, Tolerability, and Efficacy of IL-15 Superagonist (N-803) With and Without Combination Broadly Neutralizing Antibodies to Induce HIV-1 Control During Analytic Treatment Interruption

NCT04340596 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Phase I Study to Evaluate a Human Monoclonal Antibody (MAb) 10E8VLS Administered Alone or Concurrently With MAb VRC07-523LS Via Subcutaneous Injection in Healthy Adults

NCT03565315 ·Status: TERMINATED ·Phase: PHASE1

Safety of and Immune Response to an HIV-1 Subtype C Vaccine (AVX101) in HIV Uninfected Adults

NCT00097838 ·Status: COMPLETED ·Phase: PHASE1

A Phase I Clinical Trial To Evaluate the Toxicity, Antiviral and Immunomodulatory Effects of a Range of Doses of Ampligen in HIV-Infected Subjects

NCT00000713 ·Status: COMPLETED ·Phase: PHASE1

Safety of and Immune Response to an HIV-1 DNA Vaccine (VRC HIVDNA009-00-VP) in HIV Uninfected Adults

NCT00071851 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Comparing Raltegravir Genital Tract Distribution in HIV-infected Men and Women

NCT00745368 ·Status: COMPLETED ·Phase: NA

Study Evaluating Vaccine in Adults With HIV

NCT00195234 ·Status: COMPLETED ·Phase: PHASE1

Subcutaneously Administered Interleukin-2 Therapy in HIV-Infected Patients

NCT00001357 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of T Cell Genetic Immunotherapy for HIV

NCT00131560 ·Status: UNKNOWN ·Phase: PHASE2